Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by Safetyinnumberson May 02, 2019 9:13pm
147 Views
Post# 29704288

RE:RE:RE:Financials anyone?

RE:RE:RE:Financials anyone?I did post this before the delay was reported and again no response but here it is again
Why doesn’t 24k or Niet who have a line to the company answer this?

So the issue is 

  1. Why?
  2. Why haven't the announced it and is an idiot like me reporting it?
  3. Will this lead to a lively delay in reporting their results?
  4. In our space ii the hasn't gone well when an auditor resigns....

 

Toronto, Canada, March 5, 2019 – Namaste Technologies Inc. (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) confirmed today that PricewaterhouseCoopers, LLP  will no longer be acting as the Company’s auditor. The Company’s audit committee and board have accepted PwC’s resignation and are in advanced discussions with potential successor auditors, one of whom is in the final stages of its client acceptance process. The filings required under Section 4.11(5) of National Instrument 51-102- Continuous Disclosure Obligations will be made publicly available at www.sedar.com.  The Company’s annual financial statements are due to be filed by March 31, 2019. The Company currently believes that it is unlikely that it will be able to meet such filing deadline. The Company will continue to assess this and will update the market in due course.

 

To make matters worse, Namaste auditors, Price Waterhouse Cooper (PwC), resigned today and refused to continue working with the company. With Namaste now seeming unlikely to meet its annual financial statement deadlines, shares dropped around 12.5 percent following the announcement.

 

 

 

 

"The company announced that PwC formally dropped Namaste as a client only six months after the two companies came to an agreement. Currently, Namaste is looking for a replacement and “are in advanced discussions with potential successor auditors, one of whom is in the final stages of its client acceptance process,” addingthat “the Company’s annual financial statements are due to be filed by March 31, 2019. The Company currently believes that it is unlikely that it will be able to meet such a filing deadline. The Company will continue to assess this, and will update the market in due course.”https://warriortradingnews.com/2019/03/07/namastes-stock-plunges-as-auditor-price-waterhouse-cooper-resign/


Read more at https://stockhouse.com/companies/bullboard/c.huge/fsd-pharma?postid=29667365#OCuw705UXVzfJ7Do.99
Bullboard Posts